cancer |
Greulich et al., 2012, Proc. Natl. Acad. Sci. U.S.A. |
Drug Gene Knowledge Database (View variants) |
likely pathogenic |
|
urinary bladder urothelial carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
gastric adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
cervix carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
breast cancer |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
ovarian serous cystadenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
skin squamous cell carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
lung adenocarcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
head and neck squamous cell carcinoma |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|
colorectal cancer |
Chang et al., 2016, Nat. Biotechnol. |
Pan-cancer recurrent hotspots (View variants) |
likely pathogenic |
|